FAIM
INSM icon

Financial Advocates Investment Management’s Insmed INSM Stock Holding History

Financial Advocates Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,836
Closed -$369K – 701
2025
Q1 		$369K Sell
4,836
-10
-0.2% -$765 0.03% 503
2024
Q4 		$335K Buy
+4,846
New +$349K 0.02% 569

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Financial Advocates Investment Management's INSM Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Insmed (INSM) in Q2 2025, closing a stake of 4,836 shares — an estimated $369K sold.

Financial Advocates Investment Management first reported a position in INSM in Q4 2024 and held it in 2 quarters. The position peaked at $369K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 4,836 Insmed shares in Q2 2025, an estimated $369K.
  • Financial Advocates Investment Management first reported a position in Insmed in Q4 2024 and held it in 2 quarters.
  • Financial Advocates Investment Management's Insmed position peaked at $369K in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.